J Pedro Teixeira (a.k.a. Jwow)

Vertex to Seek US Approval After Promising Late-stage Results for Kidney Drug Vertex Pharmaceuticals said on Monday that its experimental drug sharply reduced a key sign of kidney ⁠damage in a late‑stage trial, putting the company on track to seek...

B cell therapies in IgAN advance: povetacicept from Vertex

www.medscape.com/s/viewarticl...

#NephMadness timing was perfect for this

Atacicept has competition now (and there’s the Chinese Telitacicept)

Extracorporeal Blood Purification Therapies in Latin America – Bridging Gaps in Availability and Training Abstract. Introduction: Socioeconomic and developmental diversity across Latin America (LA) significantly affects the availability of extracorporeal blood purification (EBP) therapies to treat acute k...

SLANH 🌎 survey (Mar–Dec 2024; n=505; 20 LA countries): EBP for AKI 👉🏻IHD 98%, PD 65%, CRRT 59% (unavailable in 🇭🇹, 🇳🇮, 🇵🇾 & 🇻🇪). Advanced EBP scarce: ECMO 16.7%, ECCO₂R 7%. Top training needs: ECMO, ECCO₂R, CRRT, TPE. @SLANH_ #AKI #EBP
🔗 doi.org/10.1159/0005...

Proud to have been part of this newly published phase 2 RCT in AKI + iron deficiency (n=120). A single 1,200 mg IV iron dextran infusion was safe but did not reduce MAKE at 90 days vs usual care (82% vs 75%; p=0.37). #AKI #Nephrology #ClinicalTrials
🔗 journals.lww.com/kidney360/ab...

A multicenter retrospective HRS-HARMONY study (11 🇺🇸 🏥 systems; n=374 cirrhosis + AKI requiring dialysis): HRS-AKI was not associated with higher 90-day mortality vs other AKI etiologies. Overall mortality 59.6%—similar to other AKI-dialysis cohorts. 🔗 journals.lww.com/kidney360/fu...

recording another episode of @freelyfiltered.bsky.social

like @nephcrit.bsky.social at BICARICU2 I was in a minroty in this discussion

thanks @ucsfnephrology.bsky.social and @nephroninja.bsky.social and Sam Silver for joining us!

FF 88 BICARICU-2, Bicarbonate in the ICU. Helpful or just a number fixer? Podcast Episode · Freely Filtered, a NephJC Podcast · 2025-12-27 · 1h 25m

Wow - excellent discussion of the totally underwhelming BICAR-ICU2 trial

podcasts.apple.com/ca/podcast/f...

@nephcrit.bsky.social fighting a line fight against the unimpressed nephrons with guest @weddellite.bsky.social

#NephSky #EMIMCC

Okay. That's been my practice too. Thanks!

From last nights fish grill (Audio on)

Discussion of steroids was very balanced. But I know you love steroids. I find this hard to navigate personally. What do you do with flu-ARDS? Hold steroids? DEXA-ARDS protocol?

Time to grill Charmaine Lok about fish oil for the next Freely Filtered with @nephcrit.bsky.social and @hswapnil.medsky.social

Kidney week slide

Excellent talk by @nephcrit.bsky.social on precision dose CRRT. #kidneywk

2025 Inductees to the AJKD Reviewer Hall of Fame In 2017, we began recognizing reviewers who have distinguished themselves by consistently providing insightful, detailed, and valuable input to our authors and our editorial team. We continue the t…

Nice of @ajkd.bsky.social to recognize this!

Congrats to @karenwoomd.bsky.social @nephcrit.bsky.social @amyaimei.bsky.social and all the others!

ajkdblog.org/2025/11/06/2...

#NephSky #KidneyWk

ICYMI, recording now live
Excellent exposition on lower doses, anti coagulation and much more. Lot of RCTs in this space

youtu.be/xfEVlh_68vc?... by @nephcrit.bsky.social #NephGR #NephSky

Pubmed Banner now saying (due to US Govt shutdown) that Notice Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

as expected, this happens, again

pubmed.ncbi.nlm.nih.gov

#Pubmed #USGovtShutdown #MedSky

splash slide

Coming up this week!

We have @nephcrit.bsky.social talking to us about CRRT

#NephGR at @uottawa.ca @ottawahospital.on.ca

Schedule

The October academic activities in nephrology at @uottawa.ca @ottawahospital.on.ca

Feat @nephcrit.bsky.social @dialysisbloke.bsky.social and @asakhuja.bsky.social

#NephGR #NephSky

ICU Snapshots:

Walking from room to room in the ICU, you see this on the monitor of a 60 yo female patient admitted the previous night with severe community-acquired pneumonia & what you were told was "refractory" septic/cardiogenic shock. Arterial line was in the R fem artery:

Renal insufficiency after oral administration of a double dose of a cholecystographic medium: report of two cases - PubMed Renal insufficiency after oral administration of a double dose of a cholecystographic medium: report of two cases

Is this the earliest description of contrast nephropathy from 1959?

@juancarlosqvelez.bsky.social

pubmed.ncbi.nlm.nih.gov/14437345/

Several aspects still key
- immediate oliguria
- recovery by 2 weeks
- false positive urine protein
- high dose contrast

#NephSky

5 Nephrologists, 1 Question: Practice-Changing Tools and Tech | Docwire News In this new recurring section, Nephrology Times asked five nephrologists: What technology or tool has changed your practice the most in the last 5 years?

Don't miss our NEW regular feature, "5 Nephrologists, 1 Question." This time, we asked about recent tools and tech that are changing nephrology practice. #nephrology #nephsky #nephrologist #kidneycare www.docwirenews.com/post/5-nephr... @jordybc.bsky.social
@nephcrit.bsky.social

Core Curriculum by @nephcrit.bsky.social , @hswapnil.medsky.social , Abdulghani Omar Kabli, Oleksa G. Rewa, and Edward G. Clark:

Continuous Kidney Replacement Therapies: Core Curriculum 2025

bit.ly/TeixeiraCC25 (FREE)

🩺💬 Ever wonder why CRRT is the go-to in the ICU? Or how to de-escalate #CKRT safely?

Kidney Commute: Pitstop dives into the latest AJKD Core Curriculum update on CKRT.

🔗 Listen now: www.kidney.org/podcasts/kid...

#MedEd #Nephrology #KidneyCare @annagaddy.bsky.social @ajkd.bsky.social

In which I become an honorary Canadian citizen 🇨🇦 @nephcrit.bsky.social @hswapnil.medsky.social

#CRRT #nephcrit #emimcc #nephsky #nephrology #ccsky #critcare #criticalcare #ICU #intensivecare #meded #medsky

UAB_CRRT_2025_WKSQ_03 This is "UAB_CRRT_2025_WKSQ_03" by Cedar Creative on Vimeo, the home for high quality videos and the people who love them.

Want to learn about CRRT in a hands-on manner in a fun and relaxed environment directly from some of the biggest experts in the world, including the Queen of CRRT herself, Dr. Tolwani??If so, you need to come to 'Bama in September!

check out the video: bitly.cx/heI5
register here: rb.gy/l49le1

Officially graduated from #CriticalCare fellowship. It’s been a unique and fulfilling journey taking a break from my #Nephrology associate professor role to return as a trainee. Strengthened my #POCUS foundation, built #TEE skills, and now looking forward to returning as #NephCrit.

⏳ One week left to apply. The Fellows’ Travel Support Scholarship gives nephrology fellows $1,000 to attend the UAB CRRT Academy. Train in person, build practical CRRT skills, and learn through simulation and expert-led sessions. Apply by Monday, July 21 👉 bit.ly/3FGntEx

In honor of the 2025 Euros, Basel, Switzerland has changed the men in the traffic lights to female football players, and we are OBSESSED with it🚦🇨🇭

🎥: @lionel_pittet

Pedro expounding on a esoteric nuance of Qb/QD in CRRT

watch out for a 🎙️episode drop with @nkf-professionals.bsky.social @kidney.org soon

@annagaddy.bsky.social @nephcrit.bsky.social Ted Clark

#NephSky

Core Curriculum by @nephcrit.bsky.social , @hswapnil.medsky.social , Abdulghani Omar Kabli, Oleksa G. Rewa, and Edward G. Clark:

Continuous Kidney Replacement Therapies: Core Curriculum 2025

bit.ly/TeixeiraCC25 (FREE)